EXACT Therapeutics to present company update

Oslo, November 25, 2025.

EXACT Therapeutics AS (Euronext Growth, Oslo: EXTX) will be presenting a company update at the DNB Carnegie Nordic Healthcare Conference on November 25, 2025.

The presentation is attached to this message, and will be made available on the company’s website www.exact-tx.com/finreports

For further information, please contact:

CEO Per Walday Per.walday@exact-tx.com

About EXACT-Tx: EXACT-Tx is a clinical-stage precision medicine company utilizing the power of ultrasound and microbubbles to enable targeted drug delivery in oncology. Acoustic Cluster Therapy (ACT®) follows a unique approach and may be applied to a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy) and brain diseases. www.exact-tx.com